Esperion Therapeutics
ESPR
#6169
Rank
C$1.22 B
Marketcap
C$5.15
Share price
-1.58%
Change (1 day)
10.03%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of September 2025 : C$0.12 Billion

According to Esperion Therapeutics's latest financial reports the company has C$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.20 B90.42%
2023-12-31C$0.10 B-51.82%
2022-12-31C$0.22 B-31.49%
2021-12-31C$0.33 B-15%
2020-12-31C$0.38 B48.28%
2019-12-31C$0.26 B41.52%
2018-12-31C$0.18 B-26.38%
2017-12-31C$0.25 B-11.48%
2016-12-31C$0.28 B-3.43%
2015-12-31C$0.29 B139.73%
2014-12-31C$0.12 B92.11%
2013-12-31C$63.93 M887.42%
2012-12-31C$6.47 M305.17%
2011-12-31C$1.59 M
2002-12-31C$70.84 M-36.73%
2001-12-31C$0.11 B6.42%
2000-12-31C$0.10 B1135.61%
1999-12-31C$8.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$0.58 B 359.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.04 B 1,498.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.70 B 16,108.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$11.66 B 9,033.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.36 B 185.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.16 B 25.42%๐Ÿ‡บ๐Ÿ‡ธ USA